Cargando…

High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study

BACKGROUND: Post COVID-19 syndrome (PCS) has emerged as a major roadblock in the recovery of patients infected with SARS-CoV-2. Amongst many symptoms like myalgia, headache, cough, breathlessness; fatigue is is most prevalent and makes the patient severely debilitated. Research on PCS, in particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Juhi, Ghosh, Amerta, Bhatt, Surya Prakash, Anoop, Shajith, Ansari, Irshad Ahmad, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462068/
https://www.ncbi.nlm.nih.gov/pubmed/34626924
http://dx.doi.org/10.1016/j.dsx.2021.102302
_version_ 1784572121131778048
author Mittal, Juhi
Ghosh, Amerta
Bhatt, Surya Prakash
Anoop, Shajith
Ansari, Irshad Ahmad
Misra, Anoop
author_facet Mittal, Juhi
Ghosh, Amerta
Bhatt, Surya Prakash
Anoop, Shajith
Ansari, Irshad Ahmad
Misra, Anoop
author_sort Mittal, Juhi
collection PubMed
description BACKGROUND: Post COVID-19 syndrome (PCS) has emerged as a major roadblock in the recovery of patients infected with SARS-CoV-2. Amongst many symptoms like myalgia, headache, cough, breathlessness; fatigue is is most prevalent and makes the patient severely debilitated. Research on PCS, in particular fatigue, in patients with diabetes has not been done. METHODOLOGY: In this prospective study, we included patients with type 2 diabetes (T2D) who had COVID-19 (mild to moderate severity), and matched T2D patients who did not suffer from COVID-19. Demography, anthropometry, glycemic measures, treatment, and details of COVID-19 were recorded. Symptoms were scored using Chalder Fatigue Scale (reported as fatigue score, FS) and handgrip strength (in kg) was recorded by Jamar Hydraulic Hand Dynamometer. RESULTS: A total of 108 patients were included (cases, 52, controls, 56). Both groups were matched for age, duration of diabetes, BMI, TSH, serum albumin and vitamin D levels. T2D patients who had COVID-19 showed significantly more fatigue when compared with patients who did not have COVID-19 but both groups had comparable handgrip strength. Furthermore, patients with T2D with previous COVID-19 infection and who had FS > 4 have had significant higher inflammation markers during acute illness, and post COVID-19, had increased post prandial blood glucose levels, lost more weight, had reduced physical activity and showed significantly lower handgrip strength as compared to those with FS < 4. CONCLUSION: Patients with T2D who had COVID-19 infection as compared to those without had significantly more fatigue after the acute illness, and those with higher FS had reduced handgrip strength indicating sarcopenia, even after careful matching for common contributory factors to fatigue at baseline. Rehabilitation of those with FS>4 after acute infection would require careful attention to nutrition, glycemic control and graduated physical activity protocol.
format Online
Article
Text
id pubmed-8462068
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Diabetes India. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84620682021-09-27 High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study Mittal, Juhi Ghosh, Amerta Bhatt, Surya Prakash Anoop, Shajith Ansari, Irshad Ahmad Misra, Anoop Diabetes Metab Syndr Original Article BACKGROUND: Post COVID-19 syndrome (PCS) has emerged as a major roadblock in the recovery of patients infected with SARS-CoV-2. Amongst many symptoms like myalgia, headache, cough, breathlessness; fatigue is is most prevalent and makes the patient severely debilitated. Research on PCS, in particular fatigue, in patients with diabetes has not been done. METHODOLOGY: In this prospective study, we included patients with type 2 diabetes (T2D) who had COVID-19 (mild to moderate severity), and matched T2D patients who did not suffer from COVID-19. Demography, anthropometry, glycemic measures, treatment, and details of COVID-19 were recorded. Symptoms were scored using Chalder Fatigue Scale (reported as fatigue score, FS) and handgrip strength (in kg) was recorded by Jamar Hydraulic Hand Dynamometer. RESULTS: A total of 108 patients were included (cases, 52, controls, 56). Both groups were matched for age, duration of diabetes, BMI, TSH, serum albumin and vitamin D levels. T2D patients who had COVID-19 showed significantly more fatigue when compared with patients who did not have COVID-19 but both groups had comparable handgrip strength. Furthermore, patients with T2D with previous COVID-19 infection and who had FS > 4 have had significant higher inflammation markers during acute illness, and post COVID-19, had increased post prandial blood glucose levels, lost more weight, had reduced physical activity and showed significantly lower handgrip strength as compared to those with FS < 4. CONCLUSION: Patients with T2D who had COVID-19 infection as compared to those without had significantly more fatigue after the acute illness, and those with higher FS had reduced handgrip strength indicating sarcopenia, even after careful matching for common contributory factors to fatigue at baseline. Rehabilitation of those with FS>4 after acute infection would require careful attention to nutrition, glycemic control and graduated physical activity protocol. Diabetes India. Published by Elsevier Ltd. 2021 2021-09-24 /pmc/articles/PMC8462068/ /pubmed/34626924 http://dx.doi.org/10.1016/j.dsx.2021.102302 Text en © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Mittal, Juhi
Ghosh, Amerta
Bhatt, Surya Prakash
Anoop, Shajith
Ansari, Irshad Ahmad
Misra, Anoop
High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
title High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
title_full High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
title_fullStr High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
title_full_unstemmed High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
title_short High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
title_sort high prevalence of post covid-19 fatigue in patients with type 2 diabetes: a case-control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462068/
https://www.ncbi.nlm.nih.gov/pubmed/34626924
http://dx.doi.org/10.1016/j.dsx.2021.102302
work_keys_str_mv AT mittaljuhi highprevalenceofpostcovid19fatigueinpatientswithtype2diabetesacasecontrolstudy
AT ghoshamerta highprevalenceofpostcovid19fatigueinpatientswithtype2diabetesacasecontrolstudy
AT bhattsuryaprakash highprevalenceofpostcovid19fatigueinpatientswithtype2diabetesacasecontrolstudy
AT anoopshajith highprevalenceofpostcovid19fatigueinpatientswithtype2diabetesacasecontrolstudy
AT ansariirshadahmad highprevalenceofpostcovid19fatigueinpatientswithtype2diabetesacasecontrolstudy
AT misraanoop highprevalenceofpostcovid19fatigueinpatientswithtype2diabetesacasecontrolstudy